Fifty-five, pensionless and assuming he’d have to work until he died, Roger Ulrich had a decision to make. After two decades in the pharmaceutical industry, his position at Merck & Co. had been phased out.
Merck & Co.’s cancer drug being evaluated in nine different malignancies kept more than four of five melanoma patients alive for a year in a study, including some who had exhausted all other treatment options.
Diabetes kills one person every six seconds and afflicts 382 million people worldwide, according to the International Diabetes Federation, which has been canvassing the help of people ranging from celebrity chef Jamie Oliver to Bob Marley’s nephew to raise awareness about the problem.
The $2.7 trillion U.S. health-care system lags behind other nations in improving its citizens’ health even as spending has doubled, increasing faster than any other industry over the past decade, researchers said.
Oncologist Bhawna Sirohi hurries to the front of a packed seminar room at Mumbai’s Tata Memorial Hospital on a Thursday afternoon in April. Cramming this meeting into her 12-hour workday, she greets more than three dozen breast cancer patients united by the bright scarves covering their bald heads.
As Scotland’s nationalists dangle the prospect of a shorter working life than in England ahead of next year’s referendum on independence, demographers say the numbers behind their proposal don’t add up.
Higher death rates among blacks in the U.S. due to heart disease, cancer, homicide, diabetes and childbirth conditions drive a persistent gap in life expectancy for the group compared with whites, a government study found.